Daisuke Tomita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daisuke Tomita has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Hiroya Kuroyanagi
Department of Gastroenterological Surgery, Toranomon Hospital
7 shared publicationsShuichiro Matoba
Department of Gastroenterological Surgery, Toranomon Hospital
6 shared publicationsYasuhiro Takahashi
Department of Gastroenterological Surgery, Toranomon Hospital
4 shared publicationsJumpei Kashiwagi
Department of Gastroenterological Surgery, Toranomon Hospital
3 shared publicationsKosuke Hiramatsu
Department of Gastroenterological Surgery, Toranomon Hospital
3 shared publicationsShigeo Toda
Department of Gastroenterological Surgery, Toranomon Hospital
3 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1859826
Case Report: Neoadjuvant FOLFOXIRI followed by laparoscopic en bloc resection and psoas hitch reconstruction for locally advanced colorectal cancer with suspected ureteral invasion: a three-case series
Radical resection is essential for achieving R0 resection and improving prognosis in patients with locally advanced colorectal cancer (CRC) involving adjacent organs. When combined ureteral resection is required, urinary tract reconstruction is critical, as it influences both the risk of complications and postoperative quality of life. Here, we report three cases of locally advanced CRC with suspected ureteral invasion, treated with neoadjuvant chemotherapy (NAC) followed by laparoscopic tumor resection and ureteral reconstruction using the psoas hitch technique, which avoids the use of intestinal segments. Three patients with locally advanced CRC and suspected ureteral involvement received six cycles of FOLFOXIRI-based neoadjuvant chemotherapy (with panitumumab added in one patient). After significant tumor shrinkage, laparoscopic radical resection, including combined ureteral resection, was performed. Ureteroneocystostomy was carried out under direct vision through a lower transverse (Pfannenstiel) incision. Operative times ranged from 505 to 727 min, with no major complications. Postoperative histopathology revealed ypT3N0M0, ypT3N1aM0, and ypT4bN1bM0, respectively, with no pathological evidence of ureteral invasion. All patients received adjuvant chemotherapy and remain recurrence-free to date. Renal function was preserved postoperatively in all cases. We describe three cases in which neoadjuvant chemotherapy effectively shrank locally advanced CRC, yet combined ureteral resection was still necessary to ensure a secure R0 resection. Our approach enabled curative resection while preserving renal function and allowing for the timely initiation of adjuvant chemotherapy. When appropriate cases are selected, the psoas hitch technique can be a feasible and safe method for ureteral reconstruction.
- 21 September 2026
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 13, 1859826
Open AccessCase Report: Neoadjuvant FOLFOXIRI followed by laparoscopic en bloc resection and psoas hitch reconstruction for locally advanced colorectal cancer with suspected ureteral invasion: a three-case series
Radical resection is essential for achieving R0 resection and improving prognosis in patients with locally advanced colorectal cancer (CRC) involving adjacent organs. When combined ureteral resection is required, urinary tract reconstruction is critical, as it influences both the risk of complications and postoperative quality of life. Here, we report three cases of locally advanced CRC with suspected ureteral invasion, treated with neoadjuvant chemotherapy (NAC) followed by laparoscopic tumor resection and ureteral reconstruction using the psoas hitch technique, which avoids the use of intestinal segments. Three patients with locally advanced CRC and suspected ureteral involvement received six cycles of FOLFOXIRI-based neoadjuvant chemotherapy (with panitumumab added in one patient). After significant tumor shrinkage, laparoscopic radical resection, including combined ureteral resection, was performed. Ureteroneocystostomy was carried out under direct vision through a lower transverse (Pfannenstiel) incision. Operative times ranged from 505 to 727 min, with no major complications. Postoperative histopathology revealed ypT3N0M0, ypT3N1aM0, and ypT4bN1bM0, respectively, with no pathological evidence of ureteral invasion. All patients received adjuvant chemotherapy and remain recurrence-free to date. Renal function was preserved postoperatively in all cases. We describe three cases in which neoadjuvant chemotherapy effectively shrank locally advanced CRC, yet combined ureteral resection was still necessary to ensure a secure R0 resection. Our approach enabled curative resection while preserving renal function and allowing for the timely initiation of adjuvant chemotherapy. When appropriate cases are selected, the psoas hitch technique can be a feasible and safe method for ureteral reconstruction.
- Open Access
- 19 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6603
Robotic-Assisted Total Pelvic Exenteration for Rectal Cancer Using the Hugo™ RAS System: First Case Report
Introduction: Total pelvic exenteration (TPE) is a radical procedure for advanced pelvic malignancies involving adjacent organs. The Hugo™ RAS System is a novel robotic platform, but its application in TPE has not previously been reported. We describe the first case of robotic-assisted TPE using Hugo™ RAS in a patient with locally advanced rectal cancer invading the prostate. Methods: A 69-year-old male with mucous and bloody stools was diagnosed with cT4b (prostate, levator ani muscle) N0M0 rectal cancer. After short-course radiotherapy (25 Gy/5 fractions), robotic-assisted TPE was performed. Port placement was planned to coincide with future colostomy and urostomy sites to minimize abdominal wall trauma. En bloc resection was achieved, followed by pelvic reconstruction with a gluteus maximus musculocutaneous flap and fascia lata autograft. Urinary diversion was completed with a robotic intracorporeal Wallace-type ileal conduit. Results: The operation lasted 17 h 56 min, with 175 mL blood loss. Postoperatively, Clavien–Dindo grade IIIa paralytic ileus occurred but was managed conservatively. Pathology revealed pT4b (prostate) N1a M0 disease with negative circumferential margin (11 mm). No recurrence was observed at 9 months. Conclusions: This case highlights the technical feasibility and safety of Hugo™ RAS-assisted TPE. Further clinical experience is needed to confirm reproducibility and oncologic safety.
- 19 September 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (18) , 6603
Open AccessRobotic-Assisted Total Pelvic Exenteration for Rectal Cancer Using the Hugo™ RAS System: First Case Report
Introduction: Total pelvic exenteration (TPE) is a radical procedure for advanced pelvic malignancies involving adjacent organs. The Hugo™ RAS System is a novel robotic platform, but its application in TPE has not previously been reported. We describe the first case of robotic-assisted TPE using Hugo™ RAS in a patient with locally advanced rectal cancer invading the prostate. Methods: A 69-year-old male with mucous and bloody stools was diagnosed with cT4b (prostate, levator ani muscle) N0M0 rectal cancer. After short-course radiotherapy (25 Gy/5 fractions), robotic-assisted TPE was performed. Port placement was planned to coincide with future colostomy and urostomy sites to minimize abdominal wall trauma. En bloc resection was achieved, followed by pelvic reconstruction with a gluteus maximus musculocutaneous flap and fascia lata autograft. Urinary diversion was completed with a robotic intracorporeal Wallace-type ileal conduit. Results: The operation lasted 17 h 56 min, with 175 mL blood loss. Postoperatively, Clavien–Dindo grade IIIa paralytic ileus occurred but was managed conservatively. Pathology revealed pT4b (prostate) N1a M0 disease with negative circumferential margin (11 mm). No recurrence was observed at 9 months. Conclusions: This case highlights the technical feasibility and safety of Hugo™ RAS-assisted TPE. Further clinical experience is needed to confirm reproducibility and oncologic safety.
- Open Access
- 15 August 2025
- Published by MDPI AG in Preprints.org
Robotic-Assisted Total Pelvic Exenteration for Rectal Cancer Using the Hugo™ RAS System: First Case Report
Total pelvic exenteration (TPE) is a radical surgical procedure indicated for advanced pelvic malignancies involving adjacent organs. The Hugo™ RAS system, a newly introduced alternative to existing robotic platforms, has not yet been reported for use in TPE for rectal cancer. We present the first known case of robotic-assisted TPE using the Hugo™ RAS system in a patient with locally advanced rectal cancer (LARC) invading the prostate. A 69-year-old male presented with mucous and bloody stools and was diagnosed with cT4b (prostate, levator ani muscle) N0M0 rectal cancer. Following neoadjuvant short-course radiotherapy (25 Gy in 5 fractions), robotic-assisted TPE was performed. Port placement was strategically modified to overlap with the planned colostomy and urostomy sites, minimizing abdominal wall trauma. Radical en bloc resection was performed, and pelvic reconstruction was achieved using a gluteus maximus musculocutaneous flap combined with a fascia lata autograft. Urinary reconstruction was achieved with a robotic intracorporeal Wallace-type ileal conduit. The total operative time was 17 hours and 56 minutes, with an estimated blood loss of 175 mL. The postoperative course was complicated by Clavien–Dindo grade Ⅲa paralytic ileus, which resolved with conservative management. The final pathology showed pT4b (prostate) N1a M0 disease with a negative circumferential resection margin (11 mm). At 9-month follow-up, no recurrence was observed. This case demonstrates the technical feasibility and safety of robotic-assisted TPE using the Hugo™ RAS system. Further clinical experience and long-term follow-up are necessary to establish its reproducibility and oncologic safety.
- 15 August 2025
- Published by MDPI AG in Preprints.org
Open AccessRobotic-Assisted Total Pelvic Exenteration for Rectal Cancer Using the Hugo™ RAS System: First Case Report
Total pelvic exenteration (TPE) is a radical surgical procedure indicated for advanced pelvic malignancies involving adjacent organs. The Hugo™ RAS system, a newly introduced alternative to existing robotic platforms, has not yet been reported for use in TPE for rectal cancer. We present the first known case of robotic-assisted TPE using the Hugo™ RAS system in a patient with locally advanced rectal cancer (LARC) invading the prostate. A 69-year-old male presented with mucous and bloody stools and was diagnosed with cT4b (prostate, levator ani muscle) N0M0 rectal cancer. Following neoadjuvant short-course radiotherapy (25 Gy in 5 fractions), robotic-assisted TPE was performed. Port placement was strategically modified to overlap with the planned colostomy and urostomy sites, minimizing abdominal wall trauma. Radical en bloc resection was performed, and pelvic reconstruction was achieved using a gluteus maximus musculocutaneous flap combined with a fascia lata autograft. Urinary reconstruction was achieved with a robotic intracorporeal Wallace-type ileal conduit. The total operative time was 17 hours and 56 minutes, with an estimated blood loss of 175 mL. The postoperative course was complicated by Clavien–Dindo grade Ⅲa paralytic ileus, which resolved with conservative management. The final pathology showed pT4b (prostate) N1a M0 disease with a negative circumferential resection margin (11 mm). At 9-month follow-up, no recurrence was observed. This case demonstrates the technical feasibility and safety of robotic-assisted TPE using the Hugo™ RAS system. Further clinical experience and long-term follow-up are necessary to establish its reproducibility and oncologic safety.
- 11 February 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (2) , e70022
Recurrent leiomyosarcoma and peritoneal dissemination of the Douglas pouch treated with combined resection of tumour and right hemicolon and partial resection of the Douglas pouch wall by laparoscopic surgery—a video vignette
- 11 February 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (2) , e70022
Recurrent leiomyosarcoma and peritoneal dissemination of the Douglas pouch treated with combined resection of tumour and right hemicolon and partial resection of the Douglas pouch wall by laparoscopic surgery—a video vignette
- 2 February 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (2) , e70019
Laparoscopic recurrent lateral pelvic lymph node dissection accompanied by combined resection of the internal iliac artery and pelvic nerve—A video vignette
- 2 February 2025
- Published by Wiley in Colorectal Disease
- Vol. 27 (2) , e70019
Laparoscopic recurrent lateral pelvic lymph node dissection accompanied by combined resection of the internal iliac artery and pelvic nerve—A video vignette
- Open Access
- 1 January 2025
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 18 (1) , 1214-1221
Robot-Assisted Simultaneous Distal Pancreatectomy and Sigmoidectomy for Synchronous Pancreatic and Colon Tumors: A Case Report
Introduction: With advancements in cancer diagnostics and treatment, the detection of multiple primary tumors has become more common, prompting the need for effective and minimally invasive surgical strategies. Simultaneous multi-organ resections can reduce surgical stress and promote early postoperative recovery, which is particularly beneficial when timely initiation of adjuvant therapy is essential. Robot-assisted surgery offers enhanced precision and dexterity, making it a valuable option for complex multivisceral resections. In this case, we performed simultaneous robot-assisted pancreatic resection and colectomy in a patient who also required curative chemoradiotherapy for esophageal cancer, allowing for the prompt initiation of postoperative treatment. Case Presentation: The patient was a 76-year-old man diagnosed with a neuroendocrine tumor in the pancreatic tail, early-stage esophageal squamous cell carcinoma, and early-stage sigmoid colon adenocarcinoma. Surgical indications were confirmed for all three lesions. A multidisciplinary team decided to perform simultaneous robot-assisted distal pancreatectomy and sigmoidectomy using the da Vinci® Xi system, followed by curative chemoradiotherapy for the esophageal cancer. We minimized the number of additional ports (total of seven) by sharing some between the two procedures, while maintaining optimal instrument maneuverability. The total operative time was 375 min (console time, 265 min), with no perioperative complications. The patient was discharged on postoperative day 12 and subsequently underwent chemoradiotherapy for esophageal cancer. Conclusion: This case highlights the feasibility and safety of robot-assisted simultaneous distal pancreatectomy and sigmoidectomy. While robotic multivisceral resections offer several advantages, thorough preoperative planning, surgical expertise, and appropriate patient selection remain essential.
- 1 January 2025
- Published by S. Karger AG in Case Reports in Oncology
- Vol. 18 (1) , 1214-1221
Open AccessRobot-Assisted Simultaneous Distal Pancreatectomy and Sigmoidectomy for Synchronous Pancreatic and Colon Tumors: A Case Report
Introduction: With advancements in cancer diagnostics and treatment, the detection of multiple primary tumors has become more common, prompting the need for effective and minimally invasive surgical strategies. Simultaneous multi-organ resections can reduce surgical stress and promote early postoperative recovery, which is particularly beneficial when timely initiation of adjuvant therapy is essential. Robot-assisted surgery offers enhanced precision and dexterity, making it a valuable option for complex multivisceral resections. In this case, we performed simultaneous robot-assisted pancreatic resection and colectomy in a patient who also required curative chemoradiotherapy for esophageal cancer, allowing for the prompt initiation of postoperative treatment. Case Presentation: The patient was a 76-year-old man diagnosed with a neuroendocrine tumor in the pancreatic tail, early-stage esophageal squamous cell carcinoma, and early-stage sigmoid colon adenocarcinoma. Surgical indications were confirmed for all three lesions. A multidisciplinary team decided to perform simultaneous robot-assisted distal pancreatectomy and sigmoidectomy using the da Vinci® Xi system, followed by curative chemoradiotherapy for the esophageal cancer. We minimized the number of additional ports (total of seven) by sharing some between the two procedures, while maintaining optimal instrument maneuverability. The total operative time was 375 min (console time, 265 min), with no perioperative complications. The patient was discharged on postoperative day 12 and subsequently underwent chemoradiotherapy for esophageal cancer. Conclusion: This case highlights the feasibility and safety of robot-assisted simultaneous distal pancreatectomy and sigmoidectomy. While robotic multivisceral resections offer several advantages, thorough preoperative planning, surgical expertise, and appropriate patient selection remain essential.
- 1 January 2025
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 18 (1) , e70051
Laparoscopic Surgery for Advanced Transverse Colon Cancer With Gastric Invasion on a Child‐Pugh Grade B Liver Cirrhosis Patient
In high‐risk patients undergoing surgery for colorectal cancer with organ invasion, a thorough evaluation of surgical indications and careful selection of optimal approaches is essential. We report a case of advanced transverse colon cancer with gastric invasion in a 58‐year‐old male with Child‐Pugh grade B liver cirrhosis. The patient underwent laparoscopic transverse colectomy combined with gastric wedge resection. Intraoperative upper gastrointestinal endoscopy facilitated precise gastric resection. The primary tumor was excised with a clear margin, and the postoperative course was uneventful. This case highlights the feasibility of laparoscopic surgery for locally advanced colorectal cancer with organ invasion in high‐risk cirrhotic patients, emphasizing the importance of meticulous operative planning and minimally invasive approaches to optimize outcomes.
- 1 January 2025
- Published by Wiley in Asian Journal of Endoscopic Surgery
- Vol. 18 (1) , e70051
Laparoscopic Surgery for Advanced Transverse Colon Cancer With Gastric Invasion on a Child‐Pugh Grade B Liver Cirrhosis Patient
In high‐risk patients undergoing surgery for colorectal cancer with organ invasion, a thorough evaluation of surgical indications and careful selection of optimal approaches is essential. We report a case of advanced transverse colon cancer with gastric invasion in a 58‐year‐old male with Child‐Pugh grade B liver cirrhosis. The patient underwent laparoscopic transverse colectomy combined with gastric wedge resection. Intraoperative upper gastrointestinal endoscopy facilitated precise gastric resection. The primary tumor was excised with a clear margin, and the postoperative course was uneventful. This case highlights the feasibility of laparoscopic surgery for locally advanced colorectal cancer with organ invasion in high‐risk cirrhotic patients, emphasizing the importance of meticulous operative planning and minimally invasive approaches to optimize outcomes.
- Open Access
- 18 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58513
A Case of Direct-Acting Oral Anticoagulant-Induced Intramural Colon Hematoma Successfully Treated by Laparoscopic Surgery
Intramural intestinal hematoma is a rare disease, one of the triggering factors of which is the use of anticoagulants. In previous reports, most patients were on treatment with warfarin. Herein, we report a case of direct-acting oral anticoagulant (DOAC)-induced intramural hematoma of the ascending colon in a patient refractory to conservative treatment and required laparoscopic right hemicolectomy. An 80-year-old male patient with a history of atrial fibrillation and cerebral infarction, on treatment with apixaban, was brought to our hospital with the chief complaints of abdominal pain, vomiting, and melena. Imaging revealed the cause of symptoms to be intestinal obstruction caused by a mass lesion on the wall of the ascending colon. We initially opted for conservative treatment with discontinuation of apixaban and insertion of an ileus tube. Intestinal dilatation findings showed improvement; however, subsequent imaging examinations did not reveal the shrinkage of a lesion in the ascending colon. If the mass was not removed, recurrence of bowel obstruction symptoms was expected, so we decided to perform surgical intervention. A laparoscopic right hemicolectomy was performed, and an intramural hematoma of the ascending colon was diagnosed based on the excised specimen. He needed a blood transfusion for anemia but was discharged on postoperative day 14 with no other complications. DOACs are now widely used in patients with atrial fibrillation, and the risk of bleeding as a side effect is extremely low compared to conventional anticoagulants, including warfarin. However, when abdominal pain occurs, as in the present case, an intramural hematoma should be considered in the differential diagnosis. There is no established treatment plan for intestinal intramural hematoma. Although conservative treatment is effective in some cases, it is difficult to evaluate the risk of bleeding associated with DOACs using coagulation tests. Even if conservative treatment is selected, it is essential to determine surgical resection, if necessary, based on the clinical course and imaging and blood test findings.
- 18 April 2024
- Published by Springer Nature in Cureus
- Vol. 16 (4) , e58513
Open AccessA Case of Direct-Acting Oral Anticoagulant-Induced Intramural Colon Hematoma Successfully Treated by Laparoscopic Surgery
Intramural intestinal hematoma is a rare disease, one of the triggering factors of which is the use of anticoagulants. In previous reports, most patients were on treatment with warfarin. Herein, we report a case of direct-acting oral anticoagulant (DOAC)-induced intramural hematoma of the ascending colon in a patient refractory to conservative treatment and required laparoscopic right hemicolectomy. An 80-year-old male patient with a history of atrial fibrillation and cerebral infarction, on treatment with apixaban, was brought to our hospital with the chief complaints of abdominal pain, vomiting, and melena. Imaging revealed the cause of symptoms to be intestinal obstruction caused by a mass lesion on the wall of the ascending colon. We initially opted for conservative treatment with discontinuation of apixaban and insertion of an ileus tube. Intestinal dilatation findings showed improvement; however, subsequent imaging examinations did not reveal the shrinkage of a lesion in the ascending colon. If the mass was not removed, recurrence of bowel obstruction symptoms was expected, so we decided to perform surgical intervention. A laparoscopic right hemicolectomy was performed, and an intramural hematoma of the ascending colon was diagnosed based on the excised specimen. He needed a blood transfusion for anemia but was discharged on postoperative day 14 with no other complications. DOACs are now widely used in patients with atrial fibrillation, and the risk of bleeding as a side effect is extremely low compared to conventional anticoagulants, including warfarin. However, when abdominal pain occurs, as in the present case, an intramural hematoma should be considered in the differential diagnosis. There is no established treatment plan for intestinal intramural hematoma. Although conservative treatment is effective in some cases, it is difficult to evaluate the risk of bleeding associated with DOACs using coagulation tests. Even if conservative treatment is selected, it is essential to determine surgical resection, if necessary, based on the clinical course and imaging and blood test findings.
- Open Access
- 15 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3)
Internal Hernia Through a Mesenteric Defect Following Esophagectomy and Reconstruction With a Stomach-Preserved Ileocolic Interposition
Esophagectomy is the standard treatment for esophageal cancer and often involves the stomach as asubstitute organ for esophageal reconstruction. However, we actively perform stomach-preserved ileocolicinterposition because of its advantages in gastrointestinal function and the prevention of reflux esophagitis.Despite its benefits, few facilities perform esophageal reconstruction with ileocolic interposition; hence,postoperative complications following this procedure have rarely been reported. We present the first case ofinternal hernia through a mesenteric defect following esophagectomy and reconstruction with a stomach-preserved ileocolic interposition. This type of internal hernia after esophageal cancer surgery is a rarecomplication following a common gastric pull-up reconstruction.A 66-year-old Japanese female underwent esophagectomy and reconstruction with stomach-preservedileocolic interposition for stage I esophageal cancer. One month after surgery, the patient experiencedabdominal pain and vomiting. CT showed a dilated small bowel and a suspected postoperative adhesivebowel obstruction. Despite conservative management, the patient experienced recurrent episodes thatrequired hospitalization. Although an exact preoperative diagnosis was not made, we decided on a surgicalexploration six months after the first symptoms appeared. Laparotomy revealed an internal herniationthrough a mesenteric defect between the transverse mesocolon and the ileum mesentery following ileocolicinterposition. We then repositioned the fitted small intestine and closed the mesenteric defects. The patientrecovered uneventfully without a hernia recurrence.Minimally invasive techniques for treating esophageal cancer are becoming more common. As survival ratesimprove, the number of internal hernia cases, such as those described in this report, will likely increase.Therefore, more cases are needed to determine whether closing mesenteric defects can effectively preventherniation. However, immediate surgical treatment should be considered based on the symptoms, evenwhen a preoperative diagnosis is difficult
- 15 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3)
Open AccessInternal Hernia Through a Mesenteric Defect Following Esophagectomy and Reconstruction With a Stomach-Preserved Ileocolic Interposition
Esophagectomy is the standard treatment for esophageal cancer and often involves the stomach as asubstitute organ for esophageal reconstruction. However, we actively perform stomach-preserved ileocolicinterposition because of its advantages in gastrointestinal function and the prevention of reflux esophagitis.Despite its benefits, few facilities perform esophageal reconstruction with ileocolic interposition; hence,postoperative complications following this procedure have rarely been reported. We present the first case ofinternal hernia through a mesenteric defect following esophagectomy and reconstruction with a stomach-preserved ileocolic interposition. This type of internal hernia after esophageal cancer surgery is a rarecomplication following a common gastric pull-up reconstruction.A 66-year-old Japanese female underwent esophagectomy and reconstruction with stomach-preservedileocolic interposition for stage I esophageal cancer. One month after surgery, the patient experiencedabdominal pain and vomiting. CT showed a dilated small bowel and a suspected postoperative adhesivebowel obstruction. Despite conservative management, the patient experienced recurrent episodes thatrequired hospitalization. Although an exact preoperative diagnosis was not made, we decided on a surgicalexploration six months after the first symptoms appeared. Laparotomy revealed an internal herniationthrough a mesenteric defect between the transverse mesocolon and the ileum mesentery following ileocolicinterposition. We then repositioned the fitted small intestine and closed the mesenteric defects. The patientrecovered uneventfully without a hernia recurrence.Minimally invasive techniques for treating esophageal cancer are becoming more common. As survival ratesimprove, the number of internal hernia cases, such as those described in this report, will likely increase.Therefore, more cases are needed to determine whether closing mesenteric defects can effectively preventherniation. However, immediate surgical treatment should be considered based on the symptoms, evenwhen a preoperative diagnosis is difficult
- Open Access
- 15 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3) , e56209
Laparoscopic Surgery for Sigmoid Colon Cancer in a Patient With a History of Two Renal Transplantation and Peritoneal Dialysis
The development of transplantation technology has improved the prognosis of transplantation surgery; however, the negative impact of immunosuppressive drugs has increased the number of patients with cancer after transplantation. Recently, minimally invasive surgery has become more common for cancer treatment. We report our experience of performing laparoscopic sigmoid colon resection for a patient with a history of two renal transplantations and peritoneal dialysis. A 42-year-old male patient who developed purpura nephropathy underwent renal transplantation at ages eight and 34 years. He had been on peritoneal dialysis for five years before the second transplantation. The patient was referred to our department with the chief complaint of sudden abdominal pain. After an examination of imaging, we obtained a diagnosis of sigmoid colon cancer. Despite a history of peritoneal dialysis, laparoscopic sigmoid colon resection was successfully performed without complications after confirming that there were no adhesions in the abdominal cavity. The left lower port position had to be adjusted because the transplanted kidney protruded into the left iliac fossa. No postoperative complications and graft loss occurred. In this case, laparoscopic surgery was effective in lowering the risk of damage to the transplanted kidney and safely performing the procedure. The number of colorectal cancer cases in renal transplant patients is expected to increase, and some of these patients will have a history of peritoneal dialysis, which may make surgery more difficult. The successful outcome of this case highlights that laparoscopic surgery could be viable for patients with such a complex medical history.
- 15 March 2024
- Published by Springer Nature in Cureus
- Vol. 16 (3) , e56209
Open AccessLaparoscopic Surgery for Sigmoid Colon Cancer in a Patient With a History of Two Renal Transplantation and Peritoneal Dialysis
The development of transplantation technology has improved the prognosis of transplantation surgery; however, the negative impact of immunosuppressive drugs has increased the number of patients with cancer after transplantation. Recently, minimally invasive surgery has become more common for cancer treatment. We report our experience of performing laparoscopic sigmoid colon resection for a patient with a history of two renal transplantations and peritoneal dialysis. A 42-year-old male patient who developed purpura nephropathy underwent renal transplantation at ages eight and 34 years. He had been on peritoneal dialysis for five years before the second transplantation. The patient was referred to our department with the chief complaint of sudden abdominal pain. After an examination of imaging, we obtained a diagnosis of sigmoid colon cancer. Despite a history of peritoneal dialysis, laparoscopic sigmoid colon resection was successfully performed without complications after confirming that there were no adhesions in the abdominal cavity. The left lower port position had to be adjusted because the transplanted kidney protruded into the left iliac fossa. No postoperative complications and graft loss occurred. In this case, laparoscopic surgery was effective in lowering the risk of damage to the transplanted kidney and safely performing the procedure. The number of colorectal cancer cases in renal transplant patients is expected to increase, and some of these patients will have a history of peritoneal dialysis, which may make surgery more difficult. The successful outcome of this case highlights that laparoscopic surgery could be viable for patients with such a complex medical history.